Hypomagnesemia Is Associated with an Increased Risk of Failure in Patients Diffuse Large B-Cell Lymphoma Undergoing Autologous Stem Cell Transplantation

被引:0
|
作者
Gile, Jennifer
Lopez, Camden
Ruan, Gordon
Hathcock, Matthew A.
Abeykoon, Jithma P.
McMahon, M. Molly
Villasboas, Jose C.
Porrata, Luis F.
Ansell, Stephen M.
Hogan, William J.
Witzig, Thomas E.
机构
关键词
D O I
10.1182/blood-2020-140474
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Consolidative Radiotherapy After Autologous Stem Cell Transplantation for Relapsed or Refractory Diffuse Large B-cell Lymphoma
    Coutu, Brendan G.
    Wilke, Christopher T.
    Yuan, Jianling
    Cao, Qing
    Vernon, Matthew R.
    Lee, Chung
    Bachanova, Veronika
    Dusenbery, Kathryn E.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (01): : 65 - 73
  • [32] Twenty Years of Autologous Stem Cell Transplantation in Diffuse Large B-Cell Lymphoma - a Single Center Experience
    Brito, Margarida Dantas
    de Castro Campilho, Fernando Manuel
    Ferreira, Rosa Branca
    Vaz, Carlos Pinho
    Roncon, Susana
    Campos, Antonio
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S119 - S120
  • [33] PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation
    Frigault, Matthew J.
    Armand, Philippe
    Redd, Robert A.
    Jeter, Erin
    Merryman, Reid W.
    Coleman, Kimberly C.
    Herrera, Alex F.
    Dahi, Parastoo
    Nieto, Yago
    LaCasce, Ann S.
    Fisher, David C.
    Ng, Samuel Y.
    Odejide, Oreife O.
    Freedman, Arnold S.
    Kim, Austin, I
    Crombie, Jennifer L.
    Jacobson, Caron A.
    Jacobsen, Eric D.
    Wong, Jeffrey L.
    Bsat, Jad
    Patel, Sanjay S.
    Ritz, Jerome
    Rodig, Scott J.
    Shipp, Margaret A.
    Chen, Yi-Bin
    Joyce, Robin M.
    BLOOD ADVANCES, 2020, 4 (01) : 122 - 126
  • [34] PD-1 Blockade for Diffuse Large B-Cell Lymphoma after Autologous Stem Cell Transplantation
    Chen, Yi-Bin
    Armand, Philippe
    Redd, Robert A.
    Bsat, Jad
    Merryman, Reid W.
    Coleman, Kimberly
    Herrera, Alex F.
    Dahi, Parastoo B.
    Nieto, Yago
    LaCasce, Ann S.
    Fisher, David C.
    Ng, Samuel Y.
    Odejide, Oreofe O.
    Freedman, Arnold S.
    Kim, Austin I.
    Crombie, Jennifer L.
    Jacobson, Caron A.
    Jacobsen, Eric D.
    Wong, Jeffrey L.
    Patel, Sanjay S.
    Ritz, Jerome
    Rodig, Scott J.
    Shipp, Margaret A.
    Joyce, Robin M.
    BLOOD, 2018, 132
  • [35] Disseminated Invasive Mucormycosis Infection Following Autologous Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma
    Edward R. Scheffer Cliff
    Gemma Reynolds
    Andrew Grigg
    Clinical Hematology International, 2023, 5 (2-3) : 71 - 77
  • [36] AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION IS A HIGHLY EFFECTIVE SECOND LINE OF TREATMENT FOR PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
    Krawczyk-Kulis, M.
    Kopinska, A.
    Grygoruk-Wisniowska, I.
    Helbig, G.
    Kyrcz-Krzemien, S.
    HAEMATOLOGICA, 2012, 97 : 724 - 724
  • [37] Salvage chemotherapy and autologous stem cell transplantation are inferior for relapsed or refractory primary mediastinal large B-cell lymphoma compared with diffuse large B-cell lymphoma
    Kuruvilla, John
    Pintilie, Melania
    Tsang, Richard
    Nagy, Tracy
    Keating, Armand
    Crump, Michael
    LEUKEMIA & LYMPHOMA, 2008, 49 (07) : 1329 - 1336
  • [38] Ofatumumab, Etoposide, and Cytarabine Intensive Mobilization Regimen in Patients with High-risk Relapsed/Refractory Diffuse Large B-Cell Lymphoma Undergoing Autologous Stem Cell Transplantation
    Kambhampati, Swetha
    Hunter, Bradley
    Varnavski, Andrei
    Fakhri, Bita
    Kaplan, Lawrence
    Ai, Weiyun Z.
    Pampaloni, Miguel
    Huang, Chiung-Yu
    Martin, Thomas, III
    Damon, Lloyd
    Andreadis, Charalambos B.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (04): : 246 - +
  • [39] Disease status at autologous stem cell transplantation and the cell of origin phenotype are important predictors of outcome in patients with neurologic (central nervous system) relapse of diffuse large B-cell lymphoma undergoing autologous stem cell transplantation
    Patil, Sushrut
    Spencer, Andrew
    Schwarer, Anthony
    Avery, Sharon
    Ritchie, David
    Opat, Stephen
    Wei, Andrew
    McLean, Catriona
    LEUKEMIA & LYMPHOMA, 2009, 50 (12) : 1964 - 1968
  • [40] Outcomes of patients with relapsed/refractory diffuse large B-cell lymphoma with progression of lymphoma after autologous stem cell transplantation in the rituximab era
    Nagle, Sarah J.
    Woo, Kaitlin
    Schuster, Stephen J.
    Nasta, Sunita D.
    Stadtmauer, Edward
    Mick, Rosemarie
    Svoboda, Jakub
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (10) : 890 - 894